Effects of Semaglutide in HIV-Associated Lipohypertrophy
Conditions: HIV/AIDS; Lipohypertrophy; Obesity Interventions: Drug: Semaglutide Injectable Product; Drug: Placebo Sponsors: Case Western Reserve University; Medical University of South Carolina; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Eating Disorders & Weight Management | Endocrinology | HIV AIDS | Obesity | Research | Urology & Nephrology